Evidence map›Paper›PMID 24121196›Full record

ReviewActa biomaterialia2014

Designing protein-based biomaterials for medical applications.

Jennifer E Gagner, Wookhyun Kim, Elliot L Chaikof

Abstract readReview
In one paragraph

Review in Acta biomaterialia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Annealed fractional Lévy-Itō diffusion models for protein generation.Computational and structural biotechnology journal · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Machine Learning in Tissue Engineering.Tissue engineering. Part A · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jennifer E GagnerDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, and the Wyss Institute of Biologically Inspired Engineering of Harvard University, Boston, MA 02215, USA.
Wookhyun KimDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, and the Wyss Institute of Biologically Inspired Engineering of Harvard University, Boston, MA 02215, USA.
Elliot L ChaikofDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, and the Wyss Institute of Biologically Inspired Engineering of Harvard University, Boston, MA 02215, USA. Electronic address: echaikof@bidmc.harvard.edu.

Funding

A Bioinspired Small Diameter Vascular ConduitR01HL083867 · NHLBI · EMORY UNIVERSITY · PI CHAIKOF, ELLIOT · 2006 to 2010
$3.8M
Molecularly Engineered Blockade of Islet Induced Inflammatory ResponsesR01DK069275 · NIDDK · EMORY UNIVERSITY · PI CHAIKOF, ELLIOT · 2004 to 2013
$3.2M
Site-Specific Therapies To Prevent Intimal HyperplasiaR01HL106018 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CHAIKOF, ELLIOT · 2011 to 2014
$1.6M
NHLBI NIH HHS R01 HL083867NHLBI NIH HHS R01 HL106018NIDDK NIH HHS R01 DK069275
6 · The paper itself

Abstract

Biomaterials produced by nature have been honed through billions of years, evolving exquisitely precise structure-function relationships that scientists strive to emulate. Advances in genetic engineering have facilitated extensive investigations to determine how changes in even a single peptide within a protein sequence can produce biomaterials with unique thermal, mechanical and biological properties. Elastin, a naturally occurring protein polymer, serves as a model protein to determine the relationship between specific structural elements and desirable material characteristics. The modular, repetitive nature of the protein facilitates the formation of well-defined secondary structures with the ability to self-assemble into complex three-dimensional architectures on a variety of length scales. Furthermore, many opportunities exist to incorporate other protein-based motifs and inorganic materials into recombinant protein-based materials, extending the range and usefulness of these materials in potential biomedical applications. Elastin-like polypeptides (ELPs) can be assembled into 3-D architectures with precise control over payload encapsulation, mechanical and thermal properties, as well as unique functionalization opportunities through both genetic and enzymatic means. An overview of current protein-based materials, their properties and uses in biomedicine will be provided, with a focus on the advantages of ELPs. Applications of these biomaterials as imaging and therapeutic delivery agents will be discussed. Finally, broader implications and future directions of these materials as diagnostic and therapeutic systems will be explored.

Indexed as

AnimalsBiocompatible MaterialsBiomedical TechnologyElastinHumansPeptidesProteinsRecombinant ProteinsBiocompatible MaterialsElastinPeptidesProteinsRecombinant ProteinsBiomimetic materialsElastin-like peptidesMolecular imagingNanotherapeuticsRecombinant polypeptides

Identifiers

PMID24121196
PMCPMC3960372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.